Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Transcatheter Heart Valves Pipeline Products Market Report Overview

Transcatheter heart valves are synthetic valves made from biological tissues surrounded by a steel, cobalt-chromium, or nitinol stent. These valves can be either balloon expandable or self-expandable. The Transcatheter Heart Valves pipeline market research report provides comprehensive information about the Transcatheter Heart Valves pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter Heart Valves Pipeline Products Market Segments

The key segments in the Transcatheter Heart Valves Pipeline Products market are Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR), and Transcatheter Mitral Valve Implantation (TMVI). As of February 2023, Transcatheter Aortic Valve Replacement (TAVR) dominated the market.

Transcatheter Heart Valves Pipeline Products Market Analysis by Segments, 2023 (%)

Transcatheter Heart Valves Pipeline Products Market Analysis by Segments, 2023 (%)

For more segments insights into the Transcatheter Heart Valves pipeline products market, download a free report sample

Transcatheter Heart Valves Pipeline Products Market Segmentation by Territories

Some of the key territories with products in the pipeline are the US, China, Europe, Canada, Israel, Taiwan, Japan, Hong Kong, Macau, and Australia among others. As of February 2023, the US has the highest number of products in the pipeline out of them all.

Transcatheter Heart Valves Pipeline Products Market Analysis, by Territories, 2023 (%)

Transcatheter Heart Valves Pipeline Products Market Analysis, by Territories, 2023 (%)

For more territory insights into the Transcatheter Heart Valves pipeline products market, download a free report sample

Transcatheter Heart Valves Pipeline Products Market Segmentation by Regulatory Paths

The key regulatory paths followed by the Transcatheter Heart Valves pipeline products market are PMA, NMPA, CE, MDL, BOPA, MDCO, Shonin, TGA, ICAC, and 510(k). Most of the products follow the PMA pathway to enter the market.

Transcatheter Heart Valves Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

Transcatheter Heart Valves Pipeline Products Market Analysis, by Regulatory Paths, 2023 (%)

For more Transcatheter Heart Valves pipeline products regulatory path insights, download a free report sample

Transcatheter Heart Valves Pipeline Products Market - Competitive Landscape

Some of the leading companies in the Transcatheter Heart Valves pipeline products market are 3DT Holdings LLC, 4C Medical Technologies Inc, Abbott Vascular Inc, Aegis Surgical Limited, Affluent Medical SASU, Anchorvalve, Annulon, Anteris Technologies Ltd, AorTx, Inc., and Arbor Surgical Technologies, Inc.

3DT Holdings LLC (3DT): Headquartered in Indiana, USA, 3DT is a contract research organization that offers drug development and manufacturing services. It develops, manufactures, and markets drugs for the treatment of cardiovascular, metabolic disorders, diabetes, and vascular diseases.

4C Medical: 4C Medical is a medical device company developing minimally invasive therapies for structural heart disease, focusing initially on mitral regurgitation (MR) therapy and subsequently on tricuspid regurgitation therapy. The company’s implant is the first MR therapy with supra-annular positioning and atrial-only fixation.

Abbott Vascular Inc: Headquartered in California, USA, Abbott Vascular develops, manufactures, and markets cardiovascular devices. The company offers coronary intervention, peripheral intervention, and structural heart products. The company provides minimally invasive treatment for mitral regurgitation and other structural defects of the heart. It also offers education and training services for healthcare professionals.

Transcatheter Heart Valves Pipeline Products Market Report Overview

Key Segments Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Repair (TMVR), and Transcatheter Mitral Valve Implantation (TMVI)
Key Territories The US, China, Europe, Canada, Israel, Taiwan, Japan, Hong Kong, Macau, and Australia
Key Regulatory Paths PMA, NMPA, CE, MDL, BOPA, MDCO, Shonin, TGA, ICAC, and 510(k)
Leading Companies 3DT Holdings LLC, 4C Medical Technologies Inc, Abbott Vascular Inc, Aegis Surgical Limited, Affluent Medical SASU, Anchorvalve, Annulon, Anteris Technologies Ltd, AorTx, Inc., and Arbor Surgical Technologies, Inc

Scope

This report provides:

  • Extensive coverage of the transcatheter heart valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
  • The report reviews the major players involved in the development of transcatheter heart valves and lists all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage
  • Identify and understand important and diverse types of Transcatheter Heart Valves under development
  • Develop market-entry and market-expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date

3DT Holdings LLC
4C Medical Technologies Inc
Abbott Vascular Inc
Aegis Surgical Limited
Affluent Medical SASU
Anchorvalve
Annulon
Anteris Technologies Ltd
AorTx, Inc.
Arbor Surgical Technologies, Inc.
Atlas Medical
AVVie GmbH
Biotronik AG
Boston Children's Hospital
Boston Scientific Corp
Cardiac Dimensions Inc
CardioMech AS
Cardiovalve Ltd
Carena Healthcare Ltd
Cephea Valve Technologies, Inc.
Chengdu Silara Meditech Inc
Colibri Heart Valve LLC
ContiTech (Beijing) Medical Technology Co Ltd
coramaze technologies GmbH
Daidalos Solutions BV
Direct Flow Medical Inc (Inactive)
DSM Dyneema BV
Dura LLC
Edwards Lifesciences Corp
Emory University
Endoluminal Technology Research LLC
Endomimetics LLC
Enlight Medical Technologies (Shanghai) Co Ltd
Florida International University
Folda LLC
Foldax Inc
Half Moon Medical Inc
Hangzhou DeJin Medtech Co Ltd
Hangzhou Valgen Medtech Co Ltd
Hangzhou Valued Medtech Co Ltd
HighLife SAS
HLT, Inc.
InnovHeart SRL
JC Medical, Inc.
JenaValve Technology GmbH
Jenscare Scientific Co Ltd
Jiangsu Zhenyi Medical Technology Co Ltd
Jinshi Biotechnology (Changshu) Co Ltd
Kekai Life Sciences
KOKA Lifesciences Co Ltd
LaPlace Interventional Inc
Lepu Medical Technology (Beijing) Co Ltd
LivaNova PLC
Mayo Clinic
Medfree Inc
Medtentia International Ltd Oy
Medtronic Plc
Meril Life Sciences Pvt Ltd
Micro Interventional Devices, Inc.
MicroPort CardioFlow Medtech Corp
MicroPort MedBot (Shanghai) Co Ltd
MicroPort Scientific Corp
Mitral Heal
Mitralix Ltd.
MitrAssist Ltd.
Mitria Medical LLC
MValve Technologies Ltd.
Nanjing Shengde Medical Technology Co Ltd
NaviGate Cardiac Structures, Inc.
Neochord Inc
Neovasc Inc
NewMed Medical Co Ltd
North Carolina State University
Novogate Medical Ltd.
NVT AG
Nyra Medical Inc
Open Stent Solution
Opsens Inc
OrbusNeich P&F
P+F Products + Features GmbH
Peca Labs Inc
Peijia Medical Ltd
Pi-Cardia Ltd
Pipeline Medical Technologies Inc
Polares Medical SA
PolyNova Cardiovascular Inc
Polyvascular Corp
RegenaGraft
ReValve Med Inc
RUA Life Sciences Plc
SAS Cormove
Shanghai Hanyu Medical Technology Co Ltd
Shanghai Healing Medical Instruments Co Ltd
Shanghai Huihe Medical Technology Co Ltd
Shanghai Shenqi Medical Technology Co Ltd
Sino Medical Sciences Technology Inc
St. Jude Medical LLC
Stony Brook University
Strait Access Technologies (Pty) Ltd
Sutra Medical Inc
Symetis SA
The University of British Columbia
Thubrikar Aortic Valve, Inc.
Tioga Medical Inc
Trinity College Dublin
Trisol Medical Ltd
University College London
University of California
University of California San Francisco
University of Cambridge
University of Iowa
University of Pennsylvania
Valcare Medical
VALFIX Medical Ltd
Valtech Cardio Ltd
Vascudyne Inc
Vascular Concepts Ltd
Vascular Innovations Co Ltd
Venus Medtech Hangzhou Inc
Venus MedTech of America
Vesalius Cardiovascular Inc
Vvital Biomed Ltd
Xeltis AG
Youngheartvalve LLC

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 9

|1.2 List of Figures 26

2 Introduction 27

2.1 Transcatheter Heart Valves Overview 27

3 Products under Development 28

3.1 Transcatheter Heart Valves – Pipeline Products by Stage of Development 28

3.2 Transcatheter Heart Valves – Pipeline Products by Segment 29

3.3 Transcatheter Heart Valves – Pipeline Products by Territory 30

3.4 Transcatheter Heart Valves – Pipeline Products by Regulatory Path 32

3.5 Transcatheter Heart Valves – Pipeline Products by Estimated Approval Date 33

3.6 Transcatheter Heart Valves – Ongoing Clinical Trials 34

4 Transcatheter Heart Valves – Pipeline Products under Development by Companies 35

4.1 Transcatheter Heart Valves Companies – Pipeline Products by Stage of Development 35

4.2 Transcatheter Heart Valves – Pipeline Products by Stage of Development 40

5 Transcatheter Heart Valves Companies and Product Overview 47

5.1 3DT Holdings LLC Company Overview 47

5.1.1 3DT Holdings LLC Pipeline Products & Ongoing Clinical Trials Overview 47

5.2 4C Medical Technologies Inc Company Overview 48

5.2.1 4C Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.3 Abbott Vascular Inc Company Overview 52

5.3.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.4 Aegis Surgical Limited Company Overview 59

5.4.1 Aegis Surgical Limited Pipeline Products & Ongoing Clinical Trials Overview 59

5.5 Affluent Medical SASU Company Overview 60

5.5.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 60

5.6 Anchorvalve Company Overview 63

5.6.1 Anchorvalve Pipeline Products & Ongoing Clinical Trials Overview 63

5.7 Annulon Company Overview 65

5.7.1 Annulon Pipeline Products & Ongoing Clinical Trials Overview 65

5.8 Anteris Technologies Ltd Company Overview 66

5.8.1 Anteris Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.9 AorTx, Inc. Company Overview 69

5.9.1 AorTx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 69

5.10 Arbor Surgical Technologies, Inc. Company Overview 70

5.10.1 Arbor Surgical Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 70

5.11 Atlas Medical Company Overview 71

5.11.1 Atlas Medical Pipeline Products & Ongoing Clinical Trials Overview 71

5.12 AVVie GmbH Company Overview 72

5.12.1 AVVie GmbH Pipeline Products & Ongoing Clinical Trials Overview 72

5.13 Biotronik AG Company Overview 73

5.13.1 Biotronik AG Pipeline Products & Ongoing Clinical Trials Overview 73

5.14 Boston Children’s Hospital Company Overview 76

5.14.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 76

5.15 Boston Scientific Corp Company Overview 78

5.15.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 78

5.16 Cardiac Dimensions Inc Company Overview 86

5.16.1 Cardiac Dimensions Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.17 CardioMech AS Company Overview 90

5.17.1 CardioMech AS Pipeline Products & Ongoing Clinical Trials Overview 90

5.18 Cardiovalve Ltd Company Overview 93

5.18.1 Cardiovalve Ltd Pipeline Products & Ongoing Clinical Trials Overview 93

5.19 Carena Healthcare Ltd Company Overview 99

5.19.1 Carena Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 99

5.20 Cephea Valve Technologies, Inc. Company Overview 100

5.20.1 Cephea Valve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 100

5.21 Chengdu Silara Meditech Inc Company Overview 101

5.21.1 Chengdu Silara Meditech Inc Pipeline Products & Ongoing Clinical Trials Overview 101

5.22 Colibri Heart Valve LLC Company Overview 104

5.22.1 Colibri Heart Valve LLC Pipeline Products & Ongoing Clinical Trials Overview 104

5.23 ContiTech (Beijing) Medical Technology Co Ltd Company Overview 110

5.23.1 ContiTech (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 110

5.24 coramaze technologies GmbH Company Overview 111

5.24.1 coramaze technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 111

5.25 Daidalos Solutions BV Company Overview 112

5.25.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 112

5.26 Direct Flow Medical Inc (Inactive) Company Overview 113

5.26.1 Direct Flow Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 113

5.27 DSM Dyneema BV Company Overview 118

5.27.1 DSM Dyneema BV Pipeline Products & Ongoing Clinical Trials Overview 118

5.28 Dura LLC Company Overview 119

5.28.1 Dura LLC Pipeline Products & Ongoing Clinical Trials Overview 119

5.29 Edwards Lifesciences Corp Company Overview 122

5.29.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 122

5.30 Emory University Company Overview 147

5.30.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 147

5.31 Endoluminal Technology Research LLC Company Overview 149

5.31.1 Endoluminal Technology Research LLC Pipeline Products & Ongoing Clinical Trials Overview 149

5.32 Endomimetics LLC Company Overview 150

5.32.1 Endomimetics LLC Pipeline Products & Ongoing Clinical Trials Overview 150

5.33 Enlight Medical Technologies (Shanghai) Co Ltd Company Overview 151

5.33.1 Enlight Medical Technologies (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 151

5.34 Florida International University Company Overview 153

5.34.1 Florida International University Pipeline Products & Ongoing Clinical Trials Overview 153

5.35 Folda LLC Company Overview 154

5.35.1 Folda LLC Pipeline Products & Ongoing Clinical Trials Overview 154

5.36 Foldax Inc Company Overview 155

5.36.1 Foldax Inc Pipeline Products & Ongoing Clinical Trials Overview 155

5.37 Half Moon Medical Inc Company Overview 157

5.37.1 Half Moon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 157

5.38 Hangzhou DeJin Medtech Co Ltd Company Overview 160

5.38.1 Hangzhou DeJin Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 160

5.39 Hangzhou Valgen Medtech Co Ltd Company Overview 163

5.39.1 Hangzhou Valgen Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 163

5.40 Hangzhou Valued Medtech Co Ltd Company Overview 164

5.40.1 Hangzhou Valued Medtech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 164

5.41 HighLife SAS Company Overview 168

5.41.1 HighLife SAS Pipeline Products & Ongoing Clinical Trials Overview 168

5.42 HLT, Inc. Company Overview 172

5.42.1 HLT, Inc. Pipeline Products & Ongoing Clinical Trials Overview 172

5.43 InnovHeart SRL Company Overview 176

5.43.1 InnovHeart SRL Pipeline Products & Ongoing Clinical Trials Overview 176

5.44 JC Medical, Inc. Company Overview 181

5.44.1 JC Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181

5.45 JenaValve Technology GmbH Company Overview 186

5.45.1 JenaValve Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview 186

5.46 Jenscare Scientific Co Ltd Company Overview 191

5.46.1 Jenscare Scientific Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 191

5.47 Jiangsu Zhenyi Medical Technology Co Ltd Company Overview 201

5.47.1 Jiangsu Zhenyi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 201

5.48 Jinshi Biotechnology (Changshu) Co Ltd Company Overview 204

5.48.1 Jinshi Biotechnology (Changshu) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 204

5.49 Kekai Life Sciences Company Overview 206

5.49.1 Kekai Life Sciences Pipeline Products & Ongoing Clinical Trials Overview 206

5.50 KOKA Lifesciences Co Ltd Company Overview 207

5.50.1 KOKA Lifesciences Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 207

5.51 LaPlace Interventional Inc Company Overview 210

5.51.1 LaPlace Interventional Inc Pipeline Products & Ongoing Clinical Trials Overview 210

5.52 Lepu Medical Technology (Beijing) Co Ltd Company Overview 211

5.52.1 Lepu Medical Technology (Beijing) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 211

5.53 LivaNova PLC Company Overview 219

5.53.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 219

5.54 Mayo Clinic Company Overview 222

5.54.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 222

5.55 Medfree Inc Company Overview 223

5.55.1 Medfree Inc Pipeline Products & Ongoing Clinical Trials Overview 223

5.56 Medtentia International Ltd Oy Company Overview 224

5.56.1 Medtentia International Ltd Oy Pipeline Products & Ongoing Clinical Trials Overview 224

5.57 Medtronic Plc Company Overview 225

5.57.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview 225

5.58 Meril Life Sciences Pvt Ltd Company Overview 232

5.58.1 Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 232

5.59 Micro Interventional Devices, Inc. Company Overview 233

5.59.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview 233

5.60 MicroPort CardioFlow Medtech Corp Company Overview 235

5.60.1 MicroPort CardioFlow Medtech Corp Pipeline Products & Ongoing Clinical Trials Overview 235

5.61 MicroPort MedBot (Shanghai) Co Ltd Company Overview 242

5.61.1 MicroPort MedBot (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 242

5.62 MicroPort Scientific Corp Company Overview 243

5.62.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 243

5.63 Mitral Heal Company Overview 244

5.63.1 Mitral Heal Pipeline Products & Ongoing Clinical Trials Overview 244

5.64 Mitralix Ltd. Company Overview 245

5.64.1 Mitralix Ltd. Pipeline Products & Ongoing Clinical Trials Overview 245

5.65 MitrAssist Ltd. Company Overview 249

5.65.1 MitrAssist Ltd. Pipeline Products & Ongoing Clinical Trials Overview 249

5.66 Mitria Medical LLC Company Overview 250

5.66.1 Mitria Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 250

5.67 MValve Technologies Ltd. Company Overview 251

5.67.1 MValve Technologies Ltd. Pipeline Products & Ongoing Clinical Trials Overview 251

5.68 Nanjing Shengde Medical Technology Co Ltd Company Overview 252

5.68.1 Nanjing Shengde Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 252

5.69 NaviGate Cardiac Structures, Inc. Company Overview 253

5.69.1 NaviGate Cardiac Structures, Inc. Pipeline Products & Ongoing Clinical Trials Overview 253

5.70 Neochord Inc Company Overview 256

5.70.1 Neochord Inc Pipeline Products & Ongoing Clinical Trials Overview 256

5.71 Neovasc Inc Company Overview 261

5.71.1 Neovasc Inc Pipeline Products & Ongoing Clinical Trials Overview 261

5.72 NewMed Medical Co Ltd Company Overview 265

5.72.1 NewMed Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 265

5.73 North Carolina State University Company Overview 276

5.73.1 North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview 276

5.74 Novogate Medical Ltd. Company Overview 277

5.74.1 Novogate Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 277

5.75 NVT AG Company Overview 278

5.75.1 NVT AG Pipeline Products & Ongoing Clinical Trials Overview 278

5.76 Nyra Medical Inc Company Overview 282

5.76.1 Nyra Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 282

5.77 Open Stent Solution Company Overview 283

5.77.1 Open Stent Solution Pipeline Products & Ongoing Clinical Trials Overview 283

5.78 Opsens Inc Company Overview 284

5.78.1 Opsens Inc Pipeline Products & Ongoing Clinical Trials Overview 284

5.79 OrbusNeich P&F Company Overview 287

5.79.1 OrbusNeich P&F Pipeline Products & Ongoing Clinical Trials Overview 287

5.80 P+F Products + Features GmbH Company Overview 290

5.80.1 P+F Products + Features GmbH Pipeline Products & Ongoing Clinical Trials Overview 290

5.81 Peca Labs Inc Company Overview 295

5.81.1 Peca Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 295

5.82 Peijia Medical Ltd Company Overview 296

5.82.1 Peijia Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 296

5.83 Pi-Cardia Ltd Company Overview 306

5.83.1 Pi-Cardia Ltd Pipeline Products & Ongoing Clinical Trials Overview 306

5.84 Pipeline Medical Technologies Inc Company Overview 309

5.84.1 Pipeline Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 309

5.85 Polares Medical SA Company Overview 310

5.85.1 Polares Medical SA Pipeline Products & Ongoing Clinical Trials Overview 310

5.86 PolyNova Cardiovascular Inc Company Overview 314

5.86.1 PolyNova Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 314

5.87 Polyvascular Corp Company Overview 315

5.87.1 Polyvascular Corp Pipeline Products & Ongoing Clinical Trials Overview 315

5.88 RegenaGraft Company Overview 319

5.88.1 RegenaGraft Pipeline Products & Ongoing Clinical Trials Overview 319

5.89 ReValve Med Inc Company Overview 320

5.89.1 ReValve Med Inc Pipeline Products & Ongoing Clinical Trials Overview 320

5.90 RUA Life Sciences Plc Company Overview 321

5.90.1 RUA Life Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview 321

5.91 SAS Cormove Company Overview 322

5.91.1 SAS Cormove Pipeline Products & Ongoing Clinical Trials Overview 322

5.92 Shanghai Hanyu Medical Technology Co Ltd Company Overview 323

5.92.1 Shanghai Hanyu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 323

5.93 Shanghai Healing Medical Instruments Co Ltd Company Overview 329

5.93.1 Shanghai Healing Medical Instruments Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 329

5.94 Shanghai Huihe Medical Technology Co Ltd Company Overview 333

5.94.1 Shanghai Huihe Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 333

5.95 Shanghai Shenqi Medical Technology Co Ltd Company Overview 337

5.95.1 Shanghai Shenqi Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 337

5.96 Sino Medical Sciences Technology Inc Company Overview 340

5.96.1 Sino Medical Sciences Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 340

5.97 St. Jude Medical LLC Company Overview 341

5.97.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 341

5.98 Stony Brook University Company Overview 344

5.98.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 344

5.99 Strait Access Technologies (Pty) Ltd Company Overview 345

5.99.1 Strait Access Technologies (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 345

5.100 Sutra Medical Inc Company Overview 346

5.100.1 Sutra Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 346

5.101 Symetis SA Company Overview 347

5.101.1 Symetis SA Pipeline Products & Ongoing Clinical Trials Overview 347

5.102 The University of British Columbia Company Overview 356

5.102.1 The University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 356

5.103 Thubrikar Aortic Valve, Inc. Company Overview 357

5.103.1 Thubrikar Aortic Valve, Inc. Pipeline Products & Ongoing Clinical Trials Overview 357

5.104 Tioga Medical Inc Company Overview 360

5.104.1 Tioga Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 360

5.105 Trinity College Dublin Company Overview 362

5.105.1 Trinity College Dublin Pipeline Products & Ongoing Clinical Trials Overview 362

5.106 Trisol Medical Ltd Company Overview 363

5.106.1 Trisol Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 363

5.107 University College London Company Overview 364

5.107.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 364

5.108 University of California Company Overview 366

5.108.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 366

5.109 University of California San Francisco Company Overview 367

5.109.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 367

5.110 University of Cambridge Company Overview 368

5.110.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 368

5.111 University of Iowa Company Overview 369

5.111.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview 369

5.112 University of Pennsylvania Company Overview 370

5.112.1 University of Pennsylvania Pipeline Products & Ongoing Clinical Trials Overview 370

5.113 Valcare Medical Company Overview 371

5.113.1 Valcare Medical Pipeline Products & Ongoing Clinical Trials Overview 371

5.114 VALFIX Medical Ltd Company Overview 373

5.114.1 VALFIX Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 373

5.115 Valtech Cardio Ltd Company Overview 374

5.115.1 Valtech Cardio Ltd Pipeline Products & Ongoing Clinical Trials Overview 374

5.116 Vascudyne Inc Company Overview 378

5.116.1 Vascudyne Inc Pipeline Products & Ongoing Clinical Trials Overview 378

5.117 Vascular Concepts Ltd Company Overview 379

5.117.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview 379

5.118 Vascular Innovations Co Ltd Company Overview 380

5.118.1 Vascular Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 380

5.119 Venus Medtech Hangzhou Inc Company Overview 381

5.119.1 Venus Medtech Hangzhou Inc Pipeline Products & Ongoing Clinical Trials Overview 381

5.120 Venus MedTech of America Company Overview 393

5.120.1 Venus MedTech of America Pipeline Products & Ongoing Clinical Trials Overview 393

5.121 Vesalius Cardiovascular Inc Company Overview 394

5.121.1 Vesalius Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 394

5.122 Vvital Biomed Ltd Company Overview 395

5.122.1 Vvital Biomed Ltd Pipeline Products & Ongoing Clinical Trials Overview 395

5.123 Xeltis AG Company Overview 396

5.123.1 Xeltis AG Pipeline Products & Ongoing Clinical Trials Overview 396

5.124 Youngheartvalve LLC Company Overview 397

5.124.1 Youngheartvalve LLC Pipeline Products & Ongoing Clinical Trials Overview 397

6 Transcatheter Heart Valves- Recent Developments 398

6.1 Jan 17, 2023: New electromagnetic device could catapult advances in mechanobiology research into the clinical arena 398

6.2 Jan 12, 2023: FEops Appoints Euan S. Thomson, PhD as Board Chair in Support of Expanding Digital Health Goals 399

6.3 Jan 06, 2023: JenaValve Appoints Dan Dearen to Board of Directors 399

6.4 Dec 12, 2022: RUA Life Sciences confirms half-year loss and revenue 400

6.5 Dec 08, 2022: Edwards Lifesciences Announces CEO Succession Plan 400

6.6 Nov 23, 2022: Medtronic Reports Quarterly Earnings 400

6.7 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results 401

6.8 Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip’s new CEO 406

6.9 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday 406

6.10 Oct 20, 2022: Edwards Lifesciences to Host Earnings Conference Call on October 27, 2022 406

6.11 Sep 30, 2022: Natalie Caine named chief administrative officer at Mayo Clinic in Rochester 407

6.12 Sep 07, 2022: Medtronic to appear at September investor conferences 407

6.13 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results 407

6.14 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results 410

6.15 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule 413

6.16 Aug 11, 2022: Neovasc Announces Second Quarter Financial Results and Provides Corporate Update 413

6.17 Jul 21, 2022: Edwards Lifesciences to Host Earnings Conference Call on July 28, 2022 414

6.18 Jun 27, 2022: Medtronic Board appoints Lidia Fonseca as a new director 414

6.19 May 27, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results 415

6.20 May 26, 2022: Medtronic reports full year and fourth quarter fiscal year 2022 financial results announces 8% dividend increase 415

6.21 May 23, 2022: Edwards Lifesciences to Present at the Bernstein 38th Annual Strategic Decisions Conference 415

6.22 May 12, 2022: Neovasc Announces First Quarter Financial Results and Provides Corporate Update 415

6.23 Apr 29, 2022: Sino Medical Sciences Tech Announces resignation of directors and the by-election of directors and members of the Strategy Committee 417

6.24 Apr 29, 2022: Sino Medical Sciences Technology Announcement on the Appointment of Senior Management 417

6.25 Apr 28, 2022: Boston Scientific reports net sales of $3.03bn in Q1 2022 417

6.26 Apr 27, 2022: Boston Scientific Announces Results for First Quarter 2022 418

6.27 Apr 19, 2022: Edwards Lifesciences to Host Earnings Conference Call on April 26, 2022 420

6.28 Mar 31, 2022: Vizient Medical Device tech watch provides trends in transcatheter valve replacement and a model for assessing new technology in musculoskeletal care 420

6.29 Mar 30, 2022: InnovHeart appoints David Wilson as Chief Executive Officer 421

6.30 Mar 18, 2022: Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercialization of TPVR system 422

6.31 Mar 10, 2022: Neovasc Announces Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update 422

7 Appendix 425

7.1 Methodology 425

7.2 About GlobalData 428

7.3 Contact Us 428

7.4 Disclaimer 428

Frequently asked questions

Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Transcatheter Heart Valves Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.